Verona Pharma Share Discussion Threads

[haff1] 05/11/2019 11:31

and ...I made a large investment here that over those 10 years has fallen by x10 in value!

[haff1] 05/11/2019 11:29

Yes, but I've been in VRP for around 10 years now and that has always been the case... the jam tomorrow promise that has yet to arise?

[bewise2] 05/11/2019 11:20

We need news of a partnership!

[haff1] 05/11/2019 11:06

..same old......

[meijiman] 29/10/2019 14:47

I had some of these and got bored...put the money into NFX. One of the few to go right!

[timbo003] 29/10/2019 14:32

>>>>digger

Apologies,I have only just seen your post (Oct 14th)

Yes, I still have a stake here, albeit quite small nowadays. I sold a few after the 2018 AGM (when it came apparent to me that they were pursuing the wrong strategy) and a few more in August 2018 when they passed on the opportunity to purchase the Vernalis stake in Ensifentrine (for peanuts).

I do hope they do come good, but I am not prepared to take the chance of buying more at the current price, especially in the absence of a partner and an impending cash call if they wish to complete the clinical program on their own.

[haff1] 29/10/2019 11:54

This company has made very slow progress over the nearly 10 years I have been with it...very slow....

[digger18] 14/10/2019 21:28

Are you still out there Timbo?
The thread has lost momentum, unfortunately just like the company.
News should start coming through soon regarding part one of MDI.

[shearluc] 09/8/2019 09:55

Director Buy - Chairman buying 60000 can't be a bad sign

[haff1] 06/8/2019 13:15

...and low and behold it falls again.... no surprize here then..... jam tommorrow as always....

[haff1] 05/8/2019 11:55

Some but not astounding progress....we have so must share price ground to be made up...this represents a very modest response imho...

[shanur90] 05/8/2019 08:19

52 week low will do a good run off this rns

[shakin not stirred] 30/7/2019 23:14

By the time we get the update someone might wish to ask what JAk thinks of the share price and if the drug is all he reckons as no sign of Significant shareholder value. If so then in which decade should we expect to see it. Why do they reward themselves disproportionately to the share price performance and is he aware no one is currently in profit yet he has continued to recruit at will and no further advancement to our lead drug if not only drug enisfenterine in my opinion. Does he see 40p as representing significant shareholder value. Please someone ask the question. Ask Jak at what share price level does this need to reach for them to call it a day and put shareholders out of their misery. All the above my opinion and can anyone post a Nasdaq share price and how that equates at the exchange rate to the share price on aim. Sorry for being slightly as have forgotten how many shares are worth the other as seems an age ago

[haff1] 30/7/2019 09:08

Nothing in todays press release to bring joy or excitement ... or even optimism to this drawn out process, that their caution suggests all you need know as an investor!

[haff1] 15/7/2019 09:56

Ive been in VRP for nearly 10 years now!! Foolish I know but its always been jam tomorrow for 10 years with a stedily decreasing share price and value...Its so depressing its untrue. I really cant afford to come out now and have to just hope ....though I stopped holding my breadth about 6 years ago ..... no 8 years ago....that it will come to market and have been worthwhile! Trouble is will it come to market before I pass away?

[shakin not stirred] 25/4/2019 23:11

Nice big awards again excessively ridiculous as have over seen a massive decline in share price yet share scheme totalling over 400 000 for JAK. Is that correct. LOL.

[bewise2] 21/3/2019 13:28

RNS, interesting development..

[shakin not stirred] 21/1/2019 21:30

bewise WTF. Interested to see what they say next. The BOD certainly have a lot of explaining to do.

[buywell3] 14/1/2019 17:28

Mr Market is not impressed

Getting new drug compounds to market is very very difficult

As well as very very expensive ... this share needs some good news fast

Or previous happier days will soon be in the past

Primary endpoints are very important ... hence the end.

If you get my point